ROSGQ (Rosetta Genomics) Shiller PE Ratio: (As of Sep. 21, 2026)

Rosetta Genomics  (OTCPK:ROSGQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.

Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.

Rosetta Genomics Shiller PE Ratio Related Terms

The historical data trend for Rosetta Genomics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics Shiller PE Ratio Chart

Rosetta Genomics Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
Shiller PE Ratio		Get a 7-Day Free Trial					-	-	-	-	-

Rosetta Genomics Quarterly Data
	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Mar16	Jun16	Sep16	Dec16	Jun17
Shiller PE Ratio	Get a 7-Day Free Trial														-	-	-	-	-

ROSGQ vs TEAR, IDTA, ABMC: Shiller PE Ratio Comparison

For the Diagnostics & Research subindustry, Rosetta Genomics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's Shiller PE Ratio falls into.

Rosetta Genomics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Rosetta Genomics's E10 for the fiscal year that ended in Dec16 is calculated as:

For example, Rosetta Genomics's adjusted earnings per share data for the fiscal year that ended in Dec16 was:

Current CPI (Dec16) = 241.4320.

Rosetta Genomics Annual Data

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Rosetta Genomics Business Description